Interferon gamma in the treatment of chronic polyarthritis. Long-term therapy in clinical practice
Obert, H.J.; Brzoska, J.F.
Arzneimittel-Forschung 39(7): 819-822
1989
ISSN/ISBN: 0004-4172 PMID: 2506869 Document Number: 331938
Efficacy and practicability of a defined dosage scheme for interferon gamma was proved during one year's treatment in patients with rheumatoid arthritis. Interferon gamma was well tolerated. It was effective in improving blood sedimentation rate, anemia, leucocytosis and thrombocytosis as well as clinical parameters such as pain, mobility, swollen joints and morning stiffness. Concomitant medication with corticosteroids could be reduced.
Document emailed within 1 workday
Related Documents
Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645Bernardinello, E.; Cavalletto, L.; Chemello, L.; Mezzocolli, I.; Donada, C.; Benvegnú, L.; Merkel, C.; Gatta, A.; Alberti, A. 1999: Long-term clinical outcome after beta-interferon therapy in cirrhotic patients with chronic hepatitis C. TVVH Study Group Hepato-Gastroenterology 46(30): 3216-3222
Mössinger, F. 1993: Costs and financial feasibility of long-term drug therapy of chronic polyarthritis Zeitschrift für Rheumatologie 52(6): 409-412
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294
Lonauer, G.; Wagner, H.; Boerngen, U.; Goebel, K.M. 1981: Lonazolac-Ca-a non-steroidal antirheumatic agent. Long-term clinical study in chronic polyarthritis Zeitschrift für Rheumatologie 40(4): 161-164
Klein, G.; Schwann, H.; Mirtl, B.; Thumb, N.; Mayerhofer, F.; Singer, F.; Tausch, G.; Gaismayer, K.; Rieder, H.; Hartweger, A. 1988: Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study Zeitschrift für Rheumatologie 47(5): 342-346
Sampliner, R.E. 1991: Long-term effect of alpha-interferon therapy in chronic hepatitis B American Journal of Gastroenterology 86(12): 1838-1839
Inoue, O.; Yano, M. 1994: Long-term prognosis after interferon therapy in chronic hepatitis type C Nihon Rinsho. Japanese Journal of Clinical Medicine 52(7): 1828-1831
Perasso, A.; Testino, G.; Sumberaz, A.; Ansaldi, F. 1996: Long-term therapy with interferon in anti-HCV positive chronic hepatitis: is it conceivable? Minerva Medica 87(3): 69-74
Miura, H.; Arai, H.; Matsuoka, A.; Yazawa, K.; Satoh, E.; Nishimura, K.; Honda, M.; Fujioka, H. 1999: Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy Hinyokika Kiyo. Acta Urologica Japonica 45(2): 79-83
Kuloğlu, Z.; Kansu, A.; Erden, E.; Girgin, N. 2010: Efficacy of combined interferon alpha and long-term lamivudine therapy in children with chronic hepatitis B Turkish Journal of Pediatrics 52(5): 457-463
Teuber, G.; Dienes, H.P.; Meyer Zum Büschenfelde, K.H.; Gerken, G. 1996: Long-term follow-up of patients with chronic hepatitis B after interferon treatment Zeitschrift für Gastroenterologie 34(4): 230-236
Marinucci, G.; Hassan, G.; Di Giacomo, C.; Barlattani, A.; Costa, F.; Rasshofer, R.; Roggendorf, M. 1991: Long term treatment of chronic delta hepatitis with alpha recombinant interferon Progress in Clinical and Biological Research 364: 405-410
Tran, A.; Longo, F.; Saint-Paul, M.C.; Doglio, A.; Benzaken, S.; Rampal, P. 2000: Long-term lamivudine therapy for interferon-alpha- and/or adenine arabinoside monophosphate-resistant chronic hepatitis B infection. Results of a pilot study Gastroenterologie Clinique et Biologique 24(12): 1234-1235
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339
Hadidi, T. 1976: Penicillamine D in primary chronic polyarthritis. a long-term study Die Medizinische Welt 27(7): 333-336
Von Manteuffel, G.; Herbert, V.; Storck, U.; Hilgert, A.; Vetter, O.; Goebel, K.M. 1985: Symptomatic long-term therapy of polyarthritis using pirprofen Fortschritte der Medizin 103(Spec no 7a): 185-188
Saito, Y.; Saito, H.; Tada, S.; Nakamoto, N.; Horikawa, H.; Kurita, S.; Kitamura, K.; Ebinuma, H.; Ishii, H.; Hibi, T. 2005: Effect of long-term interferon therapy for refractory chronic hepatitis c: preventive effect on hepatocarcinogenesis Hepato-Gastroenterology 52(65): 1491-1496
Zielińska, W.; Korczak-Rogoń, A.; Paszkiewicz, J.; Kowalik, M.; Cummins, J.M.; Georgiades, J.A. 1996: Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients Archivum Immunologiae et Therapiae Experimentalis 44(5-6): 359-366
Casado, L.F.; Picó, M.; Gómez, C.; Ferro, M.T.; Fernández-Rañada, J.M.; Steegmann, J.L. 1997: Fluctuating molecular remission in patients with chronic myeloid leukemia with long term complete cytogenetic response after alpha interferon treatment Medicina Clinica 109(7): 251-255